* Oncorus Inc ONCR.OQ ONCR.O is expected to show no
change in
quarterly revenue when it reports results on May 2
(estimated).
*
* Refinitiv's mean analyst estimate for Oncorus Inc is for
a loss
of 70 cents per share.
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Oncorus Inc
is
$5, above its last closing price of $0.33.
This summary was machine generated April 28 at 13:24 GMT. All
figures in US dollars unless otherwise stated